Literature DB >> 1288525

Acyclovir: a decade later.

R J Whitley1, J W Gnann.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1288525     DOI: 10.1056/NEJM199209103271108

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  61 in total

Review 1.  Antiviral therapies for herpes zoster infections. Are they economically justifiable?

Authors:  K J Smith; M S Roberts
Journal:  Pharmacoeconomics       Date:  2000-08       Impact factor: 4.981

Review 2.  Neuro-intensive care of patients with acute CNS infections.

Authors:  J David Beckham; Kenneth L Tyler
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

3.  Herpes simplex virus colitis complicating the course of a patient with Crohn's disease and cirrhosis: an underestimated association?

Authors:  Jean-Baptiste Chevaux; Laurent Peyrin-Biroulet
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-02

4.  Manzamine A as a novel inhibitor of herpes simplex virus type-1 replication in cultured corneal cells.

Authors:  Jayavardhana R Palem; Gautam R Bedadala; Khalid A El Sayed; Shao-chung V Hsia
Journal:  Planta Med       Date:  2010-07-19       Impact factor: 3.352

Review 5.  [Specific infections in organ transplantation].

Authors:  M Cornberg; B Schlevogt; J Rademacher; A Schwarz; M Sandherr; G Maschmeyer
Journal:  Internist (Berl)       Date:  2016-01       Impact factor: 0.743

6.  Effect of resiquimod 0.01% gel on lesion healing and viral shedding when applied to genital herpes lesions.

Authors:  Kenneth H Fife; Tze-Chiang Meng; Daron G Ferris; Ping Liu
Journal:  Antimicrob Agents Chemother       Date:  2007-11-26       Impact factor: 5.191

7.  In Vitro and In Vivo Activity, Tolerability, and Mechanism of Action of BX795 as an Antiviral against Herpes Simplex Virus 2 Genital Infection.

Authors:  James Hopkins; Tejabhiram Yadavalli; Rahul Suryawanshi; Farreh Qatanani; Ipsita Volety; Ram Koganti; Aqsa Iqbal; Deepak Shukla
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

8.  Pharmacy Operationalization of the Intralesional Oncolytic Immunotherapy Talimogene Laherparepvec.

Authors:  Ali McBride; John Valgus; Sandeep Parsad; Erica M Sommermann; Robert Nunan
Journal:  Hosp Pharm       Date:  2018-01-10

Review 9.  Pathogenesis and current approaches to control of varicella-zoster virus infections.

Authors:  Anne A Gershon; Michael D Gershon
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

10.  Comparative activity of selected antiviral compounds against clinical isolates of varicella-zoster virus.

Authors:  G Andrei; R Snoeck; D Reymen; C Liesnard; P Goubau; J Desmyter; E De Clercq
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-04       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.